Morbid obesity is rapidly increasing globally and is the leading cause of preventable cause of death in the United States. The only effective and enduring treatment for morbid obesity remains bariatric surgery. Both the growth in the prevalence of obesity and the success of weight loss surgery has led to truly spectacular growth in utilization of bariatric surgery. Outcomes have driven both the rise and fall of bariatric surgery over time. A clear reason for the recent growth of bariatric surgery was the 2004 approval of weight loss surgery by the Centers for Medicare and Medicaid Services, which was driven by outcomes studies. In the 1970s, serious adverse outcomes associated with jejunal-ileal bypass led to its ultimate demise, uniquely becoming the only operation to be banned by the FDA. Currently, both strong consumer and insurer interest in weight loss surgery and increased societal awareness of patient safety have directed intense interest in the outcomes of bariatric surgery. Standardization of outcomes reporting in bariatric surgery has long been an issue of contention; however, recent events have demonstrated that bariatric surgery is entering a watershed in outcomes reporting.
KeywordsBariatric Surgery Gastric Bypass Morbid Obesity Cardiac Risk Factor Weight Loss Surgery
Unable to display preview. Download preview PDF.
- Centers for Medicare and Medicaid Services. Decision memo for bariatric surgery for the treatment of morbid obesity (CAG-00250R). Available at http://www.cms.hhs.gov. Accessed February 2008
- Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Ann Int Med 1991;115(12):956-961Google Scholar
- http://www.ncbi.nlm.nih.gov.laneproxy.stanford.edu/sites/entrez. Accessed April 12, 2008
- http://www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm. Accessed April 12, 2008
- http://www.sages.org/projects/outcomes/index.php. Accessed April 12, 2008